smartbax raises €1.2M Seed round
23 May 2023· Munich, Germany· health, pharma, biotech, b2b, deep_hardware
The funds will be used to advance the company's small molecule antibiotics through preclinical studies, expand the scientific team, and identify novel solutions against multi-drug resistant pathogens
Investors
LeadBoehringer Ingelheim Venture Fund
Also participating
High-Tech Gründerfonds
About smartbax
Stage
Series A
Headquarters
Munich, Germany
Founded
2021
Team Size
6–20
Sectors
healthpharmabiotechb2bdeep_hardware